CUSABIO Expands Flexible Antibody Expression for AI-Driven Antibody Discovery
CUSABIO has expanded its flexible recombinant antibody expression service for AI-driven antibody discovery, supporting projects from 1 to 1,000+ sequences with 3 mL, 10 mL and 20 mL expression options. Optional ELISA, SPR/LSPR and BLI validation enables teams to adjust wet-lab support...